Ruben A. Mesa, M.D., director of the Mays Cancer Center, discusses the outlook of three new agents being tested in clinical trials to help those living with myelofibrosis. Presentations of these trials were presented at the recent American Society of Hematologists annual meeting.
See the full OncLive story.